This assay of plasma lipoperoxidesinvolves hydrolysisin dilute H3P04 at 100 #{176}C; complexationof malondialdehyde (MDA), a hydrolysis product, with thiobarbituricacid (TBA); methanol precipitation of plasma proteins;fractionationof the protein-free extract on a C15 column; and spectrophotometnc quantification of the MDA-TBA adduct at 532 nm. The detection limit was 0.15 &mol of MDA per liter of plasma.
Plasma lipoperoxides are hydrolyzed by boiling in dilute phosphoric acid. MDA, one of the hydrolysis products, is reacted with TBA to form MDA(TBA)2 adduct (24 , 27) . Plasma proteins are precipitated with methanol and removed from the reaction mixture by centrifugation. The protein-free extract is fractionated by HPLC on a column of octadecyl silica gel, to separate the MDA-TBA adduct from interfering chromogens.
The MDA-TBA adduct is eluted from the column with methanol/phosphate buffer and quantified spectrophotometrically at 532 nm. Plasma lipoperoxide concentrations are computed by reference to a calibration curve prepared by assays of tetraethoxypropane (PEP), which undergoes hydrolysis to liberate stoichiometric amounts of MDA (28) .
MaterIals and Methods

Apparatus
Polypropylene test tubes, 13-mL capacity, with screw caps (no. 60-541-685; Walter Sarstedt, Inc., Princeton, NJ).
Polypropylene microtubes, 2-mL capacity, with screw caps that contain 0-ring seals (no. 72-693; Walter Sarstedt, Inc.).
High-speed microcentrifuge, to accommodate 2-mL microtubes.
HPW apparatus. Solvent-delivery module and injection system (Model 112, Beckman Instruments, Inc., Fullerton, CA) with 50-pL sample loop. A guard column, 3.9 mm (i.d.) x 2.3 cm, packed with Bondapak Corasil C18 (37-to 50-pm particle diameter; Waters-Millipore Corp., Milford, MA). A 3.9mm (i.d.) x 30 cm chromatographic column packed with 1zBondapak C18 (10-pm particle diameter; Waters-Mfflipore). The flow rate of the mobile phase is 2 mL/mun. Spectrophotometric monitor, variable wavelength (Model 3000; LDC/Milton Roy Co., Riviera Beach, FL), with 14-pL flow-cell volume, 1-cm optical pathlength, set at 532 nm and a sensitivity of 0.02 absorbance unit (A). Although the voltage output is nominally 10 mV, we connect the spectrophotometric monitor to a strip-chart recorder with 1 mV full-scale range (Model 9176: Varian Corp., Palo Alto, CA), so that the actual recorder sensitivity is 0.002 A full-scale. Recorder chart-speed is 1 cm/mm.
Reagents
Phosphoric acid solution, 0.44 moliL. Dilute 10 mL of "ultra-pure" H3P04 reagent (relative density 1.69, 44 .0 mo]/L, 850 g/L; J. T. Baker Co., Phillipsburg, NJ) to 1 L with water (distilled water is used throughout).
TBA solution, 42 mmol/L. Dissolve 0.6 g of 4,6- Mobile phase. Prepare the HPLC mobile phase daily, just before use. Mix 400 mL of HPLC-grade methanol and 600 mnL of potassium phosphate buffer solution in a side-arm suction flask; then de-gas by reducing the pressure for 20 mm, with vigorous magnetic mixing.
Methanol-water mixtures.
Into two side-arm suction flasks, transfer 400 and 800 mL of HPLC-grade methanol and 600 and 200 mL, respectively, of distilled water that has been ifitered through a polycarbonate ifiter. Before use for HPLC, de-gas these solutions under reduced pressure for 20 min, with vigorous magnetic stirring.
Ad4itional materials.
We also used nickel chloride (NiCl2 . 3H20; Alfa Inorganics Division, Ventron Corp., Beverly, MA), quality-control sera of human origin ("Decision Level One Control Serum" from Beckman Instruments, Inc., Brea, CA; "RIA Reference Serum" from Wien Laboratories, Inc., Succasunna, NJ), six standard reference materials (glucose, cholesterol, bilirubin, urea, uric acid, and creatinine, all from the U.S. National Bureau of Standards, Gaithersburg, MD), and 17 samples of common drugs, obtained from the respective pharmaceutical manufacturers. Erythrocyte hemolysate was prepared for interference tests by mixing 3.5 mL of heparinized whole blood from a healthy adult with 3 mL of a leukocyte separation medium ("Mono-Poly Resolving Medium," cat. no. 16-980-49; Flow Laboratories, Inc., McLean, VA), which contains a mixture of polysaccharide (Ficol-400) and sodium metrizoate (Hypaque-85) having a density of 1.114 kg/L. After centrifuging these samples at 300 x g for 30 miii in a swinging-bucket rotor, we removed the supernatant layers of plasma, leukocytes, and platelets.
The sedimented erythrocytes were washed with isotonic NaC1 solution, hemolyzed by addition of five volumes of distilled water, and centrifuged at 2000 x g for 20 mm to sediment erythrocyte envelopes. The concentration of hemoglobin in the hemolysate was measured by spectrophotometry (29) .
Procedures
Blood collection from humans. Collect the blood samples by venipuncture into 7-mL evacuated tubes containing EDTA solution as anticoagulant (10.5 mg of K2EDTA in 70 pL of water). Centrifuge the blood (900 x g, 20 miii) and remove the supernatant plasma, being careful to avoid contamination with platelets. Store the plasma at 4#{176}C for no longer than 24 h before analysis.
Blood collection from rats. Induce vasodilation of the tail by placing the rat in a warmed cage (approximately 35 #{176}C) for 10 miii. After transferring the rat to a plastic restraining cone warmed with a heating pad, excise 5mm from the tip of the tail with a scalpel; discard the first drops of blood. When the blood flows freely, collect 0.5 mL in a 0.5-mL microtube containing 0.75mg of dry K2EDTA and two plastic beads (2-mm diameter) to facilitate mixing. Centrifuge the microtube as described for human blood, and pipet duplicate 50-pL aliquots of plasma directly into the 13-mL polypropylene test tubes for lipoperoxide assay. Discard any samples with visible hemolysis.
Lipoperoxide hydrolysis and TBA reaction. In each analytical run, assay-in duplicate-reagent blanks, PEP working standard solutions, plasma specimens, and a quality-control specimen. Pipet 0.75 mL of the phosphoric acid solution into each 13-mL polypropylene test tube. Using a piston-displacement pipettor, pipet 50 pL of PEP standards, plasma specimens, and quality-control specimen into the respective tubes and vortex-mix. Add 0.25 mL of TBA solution to each tube. Add distilled water (0.50 mL for reagent blanks, 0.45 mL for PEP standards, plasma, samples, and quality-control samples) to adjust the final volume to 1.5 mL. Cap the tubes tightly and place them in a boiling water bath (100#{176}C) for 60 miii, then in an ice-water bath (0#{176}C) until the HPLC analyses are performed.
The MDA-TBA adduct is stable at acid pH but dissociates slowly at neutral or alkaline PH; thus the boiled samples must be neutralized individually within 10 mm before injection onto the HPLC column, as follows. Pipet 0.5 mL of each boiled sample into a polypropylene microtube that contains 0.5 mL of methanol-NaOH solution. Cap the tube and vortex-mix, then centrifuge the plasma and qualitycontrol samples (9500 x g, 5 miii) to sediment the precipitated plasma proteins.
HPLC assay. Equilibrate the HPLC apparatus by pumping mobile phase (methanol-phosphate buffer) at 2 mL'mun for at least 30 mm, until the recorder baseline is stable. Inject sequentially 50 pL of each blank, PEP standard, quality control, and protein-free plasma extract, recording the absorbance of each effluent at 532 nm for 10 min.
Measure the peak height of the MDA-TBA adduct, which has an average retention time of 4.2 mm, and prepare a calibration curve by plotting the peak heights of the blank and PEP standard samples. Determine the concentrations of the plasma lipoperoxides as MDA (pmolfL) from the calibration curve. Column regeneration. At the end of each HPLC run, remove the guard column and flush the injection system sequentially with 10 mL of distilled water, 10 mL of methanol, 10 mL of nitric acid solution (5 molJL), 10 mL of distilled water, and 10 mL of methanol/water (40/60 by vol). Reconnect the HPLC column, without the guard column, and regenerate the column by sequentially pumping methanol-water (40/60, 80/20, and 40/60 by vol) for 30 mm each, at 2 mL/mun. Repack the guard column daily, after cleaning the fits, discs, and fittings by boiling them in 2 moIJL nitric acid solution for 30 mm and then in distilled water for 30 miii. Before the next run, re-assemble the HPLC apparatus and inject 10 mL of methanol-water (80/20 by vol) to rinse the injection port and sample loop, followed by 10 mL of mobile phase.
With these precautions, the HPLC column should yield chromatograms with undiminished sensitivity and resolution for more than one month of steady use (>30 samples per day).
Cleaning plasticware. To clean the 13-mL polypropylene tubes, we treat them with TBA-H3P04 solution, prepared by mixing 300 mL of the dilute phosphoric acid, 100 mL of the TBA solution, and 200 mL of distilled water. The tightly capped tubes are filled, placed in a boiling water bath for 1 h, then rinsed several times with distilled water, filled with water, capped, and returned to the boiling water bath for 1 h. The tubes are drained, rinsed, and dried by evaporation.
With these precautions, the peak height for MDA-TBA in chromatograms of reagent blanks should be <4 mm.
Subjects
Our human subjects were 41 asymptomatic, adult residents of central Connecticut (20 men, 21 women, ages 21 to 56 years, medical school faculty, staff, and students), who were not receiving medications (including oral contraceptives) and who gave no history of heart disease, cancer, diabetes, or other serious illnesses. The subjects were not fasted. Blood was sampled between 08:00 and 11:00 h.
The experimental snimg1s were 59 male Fischer-344 rats (body weight 175-225 g; Charles River Breeding Laboratories, Inc., North Wilmington, MA), housed in stainlesssteel mesh cages and fed Purina rat chow and water ad libitum. The rats were fasted for 17 h before blood collection. Some of the rats received a subcutaneous injection of NiCl2 solution (250, 500, or 750 mmol per kilogram body wt) 24, 48, or 72 h before the blood was sampled, between 08:00 and 09:00 h. Control rats received a 0.2-mL subcutaneous injection of 140 mmol/L NaC1 vehicle solution 24, 48, or 72 h before blood collection.
Statistical computations (means, standard deviations, coefficients of variation, detection limits, and probability estimations by the Mann-Whitney test) were performed according to Sachs (30). mide by analyzing plasma specimens from several patients being treated with procainamide.
Resufts
Their chromatograms consistently showed dual peaks attributed to procainamide and its major metabolite, N-acetylprocainamide; this unusual chromatographic pattern helped us to recognize this source of drug interference.
Reference values were determined for lipoperoxide concentrations in plasma specimens from 41 healthy adult persons: Precision and recovery. We evaluated run-to-mn precision of lipoperoxide assays by analyses of commercial qualitycontrol sera. As indicated in Table 1 , replicate daily analyses yielded CVs of 12.6% and 8.0% for quality-control sera with lipoperoxide concentrations (as MDA) that averaged, respectively, 1.19 and 2.76 pinol/L. Analytical recovery of plasma at concentrations of 1.88 or 2.43 pmol/L averaged 98.1 (SD 7.1)% (range 88 to 114%), as listed in Table 2 . When we increased the plasma sample volume from 50 pL to 100 L, in an attempt to increase analytical sensitivity, this recovery was significantly smaller, ranging from 75 to 92%.
Anticoagulants and antioxidant.
Plasma specimens collected with EDTA as the anticoagulant, as recommended by Lee (31), could be validly stored at 4#{176}C for at least 24 h without significant increase of lipoperoxide concentrations as compared with assays performed within 1 h after venepuncture. In contrast, lipoperoxide concentrations were increased by 1.5 to 2 times after similar storage of serum or of plasma specimens collected with heparin or citrate. Addition of EDTA anticoagulant to TEP standards, in the same quantity used for blood collection, did not affect the slope of the calibration line. Addition of butylated hydroxytoluene in amounts from 0.75 to 3.0 mg per 1.5 mL of reaction mixture did not affect the yield of MDA-TBA adduct from plasma samples that were collected with EDTA anticoagulant; therefore, butylated hydroxytoluene was not included in the reaction mixture.
Tests for interference. Addition of glucose, cholesterol, urea, uric acid, creatinine, or bilirubin (in albumin solution) to plasma specimens and TEP standard solutions at the concentrations listed in Table 3 did not interfere with the assays. Addition of erythrocyte hemolysate to plasma specimens caused positive interference in plasma lipoperoxide measurements, consistent with previous findings (32). When plasma hemoglobin concentrations were increased to 175 mg/L by addition of hemolysate, apparent plasma lipoperoxide concentrations were increased by two-to fourfold.
We added 15 commonly used drugs to plasma specimens and TEP standards at concentrations listed in Table 3 and assayed to test for interference. The only drug that substantially interfered was procainamide, which formed a colored compound that was eluted from the HPLC column 3.8 mm after injection. N-Acetylprocainamide also formed a colored compound, but because its retention time was 5.5 mm, it did not interfere. We confirmed the interference by procaina- (15) , various liver disorders (4, 12, 43, 44) , burns (9) , and paraquat poisoning (45) . Although assays of serum lipoperoxides by the MDA-TBA reaction have become popular in Japan, they have achieved limited clinical acceptance elsewhere because of concerns about analytical specificity, sensitivity, reproducibility, recovery, specimen instability, and drug interference.
Our reference values for plasma lipoperoxide concentrations in healthy adults are consistent with those of Francesco et al. (8) but substantially lower than values for serum reported by previous investigators (Table 5) . We (25) , instead of trichloroacetic or phosphotungstic acids, which were used in most previous assays; and (c) greater specificity, because HPLC separation of the MDA-TBA adduct minimizes spectrophotometric interference. The improved specificity, sensitivity, reproducibility, and analytical recovery provided by the present assay should increase the acceptance of plasma lipoperoxide determinations for clinical research and diagnosis. We believe that the present method overcomes the drawbacks of previous techniques and will prove useful as a diagnostic test for lipid peroxidation in a wide spectrum of diseases. However, the technique requires stringent precautions to prevent hemolysis; to minimize platelet contamination; to remove traces of lipids and detergents from pipets, test-tubes, and HPLC fittings; and to monitor the purity of analytical reagents and solvents.
Others (47, 48) have used HPLC analysis with spectrophotometry at 267 to 270 nm to measure the production of MDA from polyenoic fatty acids during incubation in vitro with hepatic microsomes.
Close correlations were noted between results for MDA as determined by HPLC and by conventional TEA assays. Analytical sensitivity of the direct HPLC techniques, without prior formation of the MDA-TDA adduct, evidently was insufficient for plasma lipoperoxide analysis, because the reported detection limits for MDA were 7 x 10_il mol (47) and 5 x 10_12 mol (48) , respectively.
For comparisons, the MDA detection limits were 1.25 x 10_13 mol in the present study, and 1 x mol as obtained by Yu et al. (24) with a double monochromator spectrofluorometric detector. Others (49, 50) described HPLC techniques for analysis of serum lipoperoxides that involve acid hydrolysis of lipoperoxides and complezation of MDA with 1,3-diphenyl-2-thiobarbituric acid, extraction of the MDA-1,3-diphenyl-2-thiobarbituric acid adduct in acetonitrile-pyridine or butane, separation of the adduct by HPLC on a column of LiChrosorb-RP18, with elution in acetonitrile-water, and quantification of it by spectrophotometry at 537 nni (49) or fluorometry at 548 nm with excitation at 525 nm (50). Detection limits for this adduct were 1 x 10_12 mol by spectrophotometry (49), 2.4 x 1014 mol by fluorometry (50).
In rats with lipid peroxidation induced by NiC12, the time. course and magnitude of hyperlipoperoxidemia found in this study are consistent with previous data showing abovenormal concentrations of TEA chromogens in homogenates of lung, liver, and kidney (26, 33) , increased excretion of ethane and ethylene in expired breath (51), and increased concentration of conjugated dienes in hepatic microsomal lipids (33). Thus, the present findings demonstrate the applicability of the plasma lipoperoxide assay for detection of lipid peroxidation induced by xenobiotic toxicity in experimental animals.
